Krka d.d., Novo mesto

GPTKB entity

Statements (51)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
gptkbp:CEO gptkb:Jože_Colarič
gptkbp:country gptkb:Slovenia
gptkbp:exportPercentage over 94%
gptkbp:founded 1954
gptkbp:founder gptkb:Government_of_Slovenia
gptkbp:headquartersLocation Novo mesto, Slovenia
https://www.w3.org/2000/01/rdf-schema#label Krka d.d., Novo mesto
gptkbp:industry pharmaceuticals
gptkbp:legalForm gptkb:public_company
gptkbp:listedOn gptkb:Ljubljana_Stock_Exchange
gptkbp:logo Krka logo.svg
gptkbp:manufacturingFacilities gptkb:China
gptkb:Croatia
gptkb:Germany
gptkb:Poland
gptkb:Russia
gptkb:Slovenia
other countries
gptkbp:market gptkb:Central_Europe
gptkb:Western_Europe
gptkb:Eastern_Europe
gptkb:Southeastern_Europe
Overseas markets
gptkbp:namedAfter gptkb:Krka_River
gptkbp:netIncome €361 million (2022)
gptkbp:notableProduct Atoris (atorvastatin)
Bilobil (ginkgo biloba extract)
Coryol (carvedilol)
Doreta (tramadol/paracetamol)
Enap (enalapril)
Lorista (losartan)
Nolpaza (pantoprazole)
Prenessa (perindopril)
Septolete (throat lozenges)
Sorvasta (rosuvastatin)
Vasilip (simvastatin)
gptkbp:numberOfEmployees over 11,000
gptkbp:parentCompany none (independent)
gptkbp:products animal health products
generic pharmaceuticals
non-prescription products
gptkbp:R&DInvestment over €160 million (2022)
gptkbp:revenue €1.7 billion (2022)
gptkbp:servesArea worldwide
gptkbp:stockExchange gptkb:Ljubljana_Stock_Exchange
gptkbp:stockSymbol KRKG
gptkbp:subsidiary TAD Pharma GmbH
gptkbp:website https://www.krka.biz/
gptkbp:bfsParent gptkb:Krka_Novo_Mesto
gptkbp:bfsLayer 8